DongBao东宝品牌怎么样 申请店铺

我要投票 DongBao东宝在中草药行业中的票数:10 更新时间:2024-11-25
DongBao东宝是哪个国家的品牌?「DongBao东宝」是 通化东宝药业股份有限公司 旗下著名品牌。该品牌发源于吉,由创始人李一奎在1997-09-12期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
DongBao东宝怎么样

通化东宝集团有限公司坐落于中国著名的“医药城”吉林省通化市西郊,集自然美丽风光、历史人文景观、民族医药宝库为一体的兴办企业最佳之地。

1984年,年仅32岁的青年企业家李一奎以他超人的胆识和非凡的魄力,创建了白山滋补品厂。

1992年12月,组建了中国通化东宝集团。其间先后兼并了数家企业,特别是在1992年兼并了集团所在地通化县二密镇恒德村,在国内首创“以企兼农”典型范例,在全国引起强烈反响。集团成立13年来,企业规模发展之猛,多元化项目经营之广,兼并国营民企数量之多,生产设备与工艺流程之先,科研队伍研究水平之高,都堪称国内企业发展之奇迹,被业内人士誉为“东宝模式”,创造了中国企业快速蓬勃发展的神话。

东宝的制药业,以拥有世界上最先进的生物制药尖端技术而备受世人瞩目。先后研制推出了“镇脑宁”,东宝肝泰片、脑血康片等一大批国家级新药和拳头产品。在生物制药领域,集团先后投入数亿元科研经费,于1998年成功研制出具有中国独立知识产权的高科技制剂药品“甘舒霖”,填补了国内空白,使中国继美国、丹麦之后成为世界上第三个能生产基因重组人胰岛素、第二个能生产甘精胰岛素的国家,该成果被587名中国工程院院士评为中国十大科技进展新闻奖。目前,投资总额为3.5亿元的国家振兴东北老工业基地重点扶持项目——东宝基因重组人胰岛素二期扩建工程正在紧张引进和安装国外先进设备,在近两年内将达产3000公斤,满足日益增长的国内和国际市场需求。东宝集团已成为世界上具有相当规模、拥有当今先进技术的人胰岛素生产基地之一。

东宝集团坚持科学发展观,积极构建和谐型企业。1994年集团在扒宝沟建立了全国第一家由企业兴建的自然保护区;1995年先后投入600余万元,修筑507米长的堤坝和拦水坝;2003年初集团通过了国家ISO14001环境管理体系认证;使集团成为“山青、水碧、天蓝”山川秀美的生态型现代化企业,做到了经济效益与生态效益互利双赢。

今天的东宝集团,在全国人大代表、集团董事长李一奎先生的带领下,乘借国家振兴东北老工业基地的春风,励精图治,只争朝夕,为打造中国民族品牌,领跑世界生物制药技术而努力拼搏,阔步前进!

Tonghua Dongbao Group Co., Ltd. is located in the western suburb of Tonghua City, Jilin Province, a famous "medicine city" in China. It is the best place to set up an enterprise integrating natural beautiful scenery, historical and cultural landscape, and national medicine treasure house. In 1984, Li Yikui, a 32-year-old young entrepreneur, founded Baishan tonic factory with his superhuman courage and extraordinary courage. In December 1992, China Tonghua Dongbao group was established. During this period, several enterprises were merged successively, especially Hengde village, Ermi Town, Tonghua County, where the group is located in 1992. It is the first typical example of "combining enterprise with agriculture" in China, which has aroused strong repercussions all over the country. In the past 13 years since the establishment of the group, the rapid development of the enterprise scale, the wide diversification of project management, the large number of state-owned private enterprises to be merged, the first production equipment and technological process, and the high research level of scientific research team have all been regarded as the miracle of the development of domestic enterprises, known as the "Oriental model" by the insiders, and created the myth of the rapid and vigorous development of Chinese enterprises. Dongbao's pharmaceutical industry, with the most advanced biopharmaceutical technology in the world, has attracted worldwide attention. A large number of state-level new drugs and blockbuster products, such as "zhennaoning", Dongbao Gantai tablet, Naoxuekang tablet, have been developed and launched successively. In the field of biopharmaceutical, the group has successively invested hundreds of millions of yuan in scientific research funds. In 1998, the group successfully developed "gansulin", a high-tech pharmaceutical preparation with independent intellectual property rights in China, which filled in the domestic gap. After the United States and Denmark, China has become the third country in the world that can produce recombinant human insulin and the second country that can produce insulin glargine. This achievement has been ranked 587 in China Academicians of the Chinese Academy of Engineering awarded the top ten science and technology progress News Awards. At present, the second phase expansion project of Dongbao gene recombinant human insulin, a key supporting project for revitalizing the old industrial base in Northeast China with a total investment of 350 million yuan, is urgently introducing and installing foreign advanced equipment, which will reach a production capacity of 3000 kg in recent two years, meeting the growing domestic and international market demand. Dongbao group has become one of the human insulin production bases with considerable scale and advanced technology in the world. Dongbao group adheres to the scientific concept of development and actively constructs a harmonious enterprise. In 1994, the group established the first enterprise built Nature Reserve in babaogou; in 1995, it invested more than 6 million yuan to build 507 meter long dams and dams; at the beginning of 2003, the group passed the national ISO14001 environmental management system certification; the group became an ecological modern enterprise with beautiful mountains and rivers, achieving economic and ecological benefits Mutual benefit and win-win situation. Today's Dongbao group, under the leadership of Mr. Li Yikui, deputy to the National People's Congress and chairman of the group, takes advantage of the spring breeze of the country's revitalization of the old industrial base in Northeast China, makes every effort to build a Chinese national brand and lead the world's biopharmaceutical technology, and makes great progress!

本文链接: https://brand.waitui.com/f89fb8898.html

千城特选小程序码

7×24h 快讯

欧洲最大廉航被罚超8亿元

日前,西班牙消费者权益保护部门对欧洲最大廉价航空运营商瑞安航空、英国易捷航空等五家廉价航空公司,处以1.79亿欧元(约合人民币13.5亿元)的罚款,原因是这些航空公司存在对旅客随身行李额外收费等行为。其中,瑞安航空被罚金额最高,达约1.08亿欧元(约合人民币8.15亿元)。对此,西班牙航空公司协会表示将提起上诉,称这一罚款“明显违法”且违反欧盟规定。(央视财经)

12分钟前

近七成保险营销员认为AI冲击大

近日发布的《2024中国保险中介市场生态白皮书》显示,2024年约有66%的营销员认为AI对保险营销工作的冲击较大或很大,比去年上升了近2个百分点。从险企一端,也正纷纷通过科技赋能等方式,来对冲人力的压力。如险企采取了多种对营销人员的技术赋能策略,开展AI相关的教育培训,使得营销员精通数据科学与智能工具,增强竞争力。在挖掘个人特色与专长方面,险企也在加强个性化服务的提供,而非单一地依靠纯粹的技术解决方案。(北京商报)

12分钟前

十天吸引85.3万人次,2024广州国际车展闭幕

11月24日,历时十天的第二十二届广州国际汽车展览会落下帷幕,共吸引观众85.3万人次。车展期间共举办77场新闻发布会,近5000家海内外媒体机构的1.2万名记者参与报道了展会盛况。闭幕当天,适逢周末,展会也再次迎来客流高峰。有汽车品牌销售表示,最后两天过来看车的消费者大多是奔着订车而来,目的性很强。据了解,接近年底,以旧换新补贴、新车上市、车企促销等多重效应叠加效果显现,广州车展呈现出年底汽车消费旺盛活力。(广州日报)

12分钟前

OpenAI押注的1X明示下一步:让机器人跑起来

当地时间11月23日,OpenAI押注的机器人公司1X Technologies(简称1X)的AI副总裁Eric Jang发帖求推荐跑步机,“给机器人问的”,1X官方在这条帖子下回复了一个跑步小人的表情包。高管为公司机器人求跑步机,明示其机器人研发日程的下一步——让机器人完成更快速的运动,或通过跑步机进行奔跑训练。1X目前主推人形机器人NEO Beta,该产品于今年8月份发布,是专为家庭设计的人形机器人原型机。(财联社)

12分钟前

新旧准则并行期,险企财报“颠簸”前行

险企财报正在“颠簸”前行——同一家险企,去年亏损超百亿,今年盈利超百亿;资产重新分类后,综合投资收益率快速拉升……证券时报记者梳理上市险企财报和70多家人身险公司的最新偿付能力报告发现,随着保险行业进入新会计准则切换窗口期,财务数据变化加剧,呈现更多不确定性。(证券时报)

12分钟前

本页详细列出关于老拨云堂的品牌信息,含品牌所属公司介绍,老拨云堂所处行业的品牌地位及优势。
咨询